Cue Health Inc. - Understand $hlthq stock

$HLTHQ Market Cap: $1.591 Thousand

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$70.94M

TTM

Gross Margin

-93.6%

TTM

Net Earnings

-$373.5M

TTM

Current Assets

$110.4M

Q4 2023

Current Liabilities

$43.47M

Q4 2023

Current Ratio

253.9%

Q4 2023

Total Assets

$339.8M

Q4 2023

Total Liabilities

$89.54M

Q4 2023

Book Value

$250.3M

Q4 2023

Cash

$80.89M

Q4 2023

P/E

-0.000004260

Nov 29, 2024 EST

Free Cash Flow

-$153.2M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019
Revenue	$70.94M	$483.5M	$618.1M	$22.95M	$6.626M
YoY Change	-85.33%	-21.78%	2592.92%	246.41%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019
Revenue	$70.94M	$483.5M	$618.1M	$22.95M	$6.626M
Cost Of Revenue	$127.1M	$330.0M	$276.5M	$14.95M	$0.00
Gross Profit	-$56.16M	$153.5M	$341.6M	$8.002M	$6.626M
Gross Profit Margin	-79.16%	31.75%	55.26%	34.86%	100.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019
Selling, General & Admin	$89.94M	$185.7M	$108.5M	$24.65M	$5.988M
YoY Change	-51.56%	71.11%	340.23%	311.66%
% of Gross Profit		120.96%	31.77%	308.05%	90.37%
Research & Development	$150.6M	$171.5M	$42.83M	$28.48M	$21.41M
YoY Change	-12.15%	300.32%	50.39%	33.04%
% of Gross Profit		111.69%	12.54%	355.89%	323.05%
Depreciation & Amortization	$56.28M	$44.94M	$32.51M	$6.282M	$3.653M
YoY Change	25.22%	38.24%	417.49%	71.97%
% of Gross Profit		29.28%	9.52%	78.51%	55.13%
Operating Expenses	$240.6M	$357.1M	$151.3M	$53.13M	$27.39M
YoY Change	-32.64%	135.97%	184.87%	93.95%
Operating Profit	-$394.9M	-$205.7M	$190.2M	-$45.13M	-$20.77M
YoY Change	92.0%	-208.11%	-521.53%	117.3%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019
Interest Expense	$1.159M	-$645.0K	-$9.809M	-$374.0K	-$152.0K
YoY Change	-279.69%	-93.42%	2522.73%	146.05%
% of Operating Profit			-5.16%
Other Income/Expense, Net	$162.0K	$2.493M	$272.0K	$47.00K	$309.0K
YoY Change	-93.5%	816.54%	478.72%	-84.79%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019
Pretax Income	-$368.7M	-$203.8M	$119.2M	-$47.35M	-$20.61M
YoY Change	80.89%	-271.01%	-351.68%	129.8%
Income Tax	$4.793M	-$9.748M	$32.76M	$0.00	$0.00
% Of Pretax Income			27.49%
Net Earnings	-$373.5M	-$194.1M	$86.42M	-$47.35M	-$20.61M
YoY Change	92.45%	-324.56%	-282.5%	129.8%
Net Earnings / Revenue	-526.48%	-40.14%	13.98%	-206.3%	-310.99%
Basic Earnings Per Share	-$2.44	-$1.31	$0.63	-$2.90	-$1.31
Diluted Earnings Per Share	-$2.44	-$1.31	$0.59	-$2.90	-$1.31

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019
Cash & Short-Term Investments	$80.89M	$241.5M	$409.9M	$121.6M	$14.33M
YoY Change	-66.51%	-41.07%	237.13%	748.53%
Cash & Equivalents	$80.89M	$241.5M	$409.9M	$121.6M	$14.33M
Short-Term Investments
Other Short-Term Assets	$14.08M	$28.66M	$67.17M	$21.11M	$976.0K
YoY Change	-50.87%	-57.33%	218.2%	2062.91%
Inventory	$14.04M	$82.21M	$88.39M	$36.84M	$0.00
Prepaid Expenses
Receivables	$1.352M	$18.75M	$104.6M	$4.168M	$200.0K
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$110.4M	$371.2M	$670.0M	$183.7M	$15.50M
YoY Change	-70.27%	-44.61%	264.74%	1084.84%
Property, Plant & Equipment	$150.6M	$274.6M	$256.9M	$112.0M	$11.63M
YoY Change	-45.15%	6.88%	129.48%	862.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$59.17M	$31.96M	$5.435M	$18.63M	$227.0K
YoY Change	85.1%	488.11%	-70.82%	8106.17%
Total Long-Term Assets	$229.4M	$323.4M	$270.0M	$132.6M	$11.86M
YoY Change	-29.06%	19.77%	103.6%	1018.58%
Total Assets	$339.8M	$694.6M	$940.1M	$316.3M	$27.36M
YoY Change
Accounts Payable	$7.705M	$7.150M	$37.21M	$23.85M	$1.168M
YoY Change	7.76%	-80.78%	56.03%	1941.7%
Accrued Expenses	$34.44M	$60.12M	$36.65M	$9.619M	$566.0K
YoY Change	-42.71%	64.05%	280.96%	1599.47%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.157M	$2.362M	$2.621M	$6.683M	$2.977M
YoY Change	-51.02%	-9.88%	-60.78%	124.49%
Total Short-Term Liabilities	$43.47M	$71.20M	$166.9M	$155.9M	$4.751M
YoY Change	-38.95%	-57.35%	7.08%	3181.33%
Long-Term Debt	$0.00	$849.0K	$3.271M	$3.188M	$4.315M
YoY Change	-100.0%	-74.04%	2.6%	-26.12%
Other Long-Term Liabilities	$46.07M	$46.04M	$63.10M	$82.32M	$2.729M
YoY Change	0.06%	-27.04%	-23.35%	2916.53%
Total Long-Term Liabilities	$46.07M	$46.89M	$66.37M	$85.51M	$7.044M
YoY Change	-1.75%	-29.35%	-22.38%	1113.93%
Total Liabilities	$89.54M	$118.1M	$233.3M	$241.4M	$11.80M
YoY Change	-24.18%	-49.39%	-3.35%	1946.67%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019
Basic Shares Outstanding	152.9M shares	148.0M shares	52.82M shares	16.32M shares	15.76M shares
Diluted Shares Outstanding	152.9M shares	148.0M shares	59.64M shares	16.32M shares	15.76M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $1.591 Thousand

About Cue Health Inc.

Cue Health, Inc. is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. The company is headquartered in San Diego, California and currently employs 726 full-time employees. The company went IPO on 2021-09-24. The firm is engaged in providing individuals with a connected diagnostic platform that bridges the physical and virtual care continuum. Its platform, Cue Integrated Care Platform, which consists of hardware, software and diagnostic components: the Cue Health Monitoring System, which is made up of a portable, durable and reusable reader, or Cue Reader, a single-use test cartridge, or Cue Cartridge, and a sample collection wand, or Cue Wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its app and Cue Enterprise Dashboard, and its Cue Ecosystem Integrations and apps, which allow for integrations with third party applications and sensors. Its products include Cue Reader, COVID-19 Test, Cue Test Kits, Cue Care, and Cue+ Membership. The company offers solutions for home/personal, business, public sector, healthcare, retail pharmacies, entertainment and education sectors.

Industry: Laboratory Analytical Instruments Peers: ABBOTT LABORATORIES ARTIVION, INC. Axogen, Inc. Cardiovascular Systems Inc Vicarious Surgical Inc. Inogen Inc IRADIMED CORP Orthofix Medical Inc. SI-BONE, Inc. SURMODICS INC